UnitedHealth to Reduce Pediatric Prior Authorizations by Two-Thirds
By Connor Hart
UnitedHealth Group plans to stop requiring doctors to get approvals for an array of pediatric procedures, tests and services, further cutting back on a process that has long been detested by physicians and patients.
UnitedHealth, parent of the biggest U.S. health insurer, on Friday said that the changes will eliminate roughly two-thirds of prior-authorization requirements for members under the age of 18 by the end of the year.
UnitedHealthcare said it will stop requiring signoffs for many diagnostic services, routine surgical procedures and specialty care services across pediatric subspecialties such as cardiology, neurology, pulmonology and orthopedics.
The insurer will additionally introduce authorization waivers for certain procedures performed at pediatric hospitals.
UnitedHealthcare said it is conducting a rigorous and data-driven review of all pediatric prior authorization requirements in order to determine which services can be safely removed.
The rollback is part of an effort by health insurers to counter a backlash against pre-authorizations. UnitedHealthcare earlier this month said it would reduce prior authorizations by nearly a third. Rivals like CVS Health's Aetna and Cigna Group have also made moves to ease these types of reviews.
Doctors have long complained about the paperwork they must complete to get insurers' permission for care, which can lead to delays and denials, The Wall Street Journal previously reported.
Surveys of doctors and patients have shown that the insurers' validation process is a top gripe.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
May 29, 2026 07:56 ET (11:56 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
